TGF-β: the connecting link between nephropathy and fibrosis

References

• Schieppati A, Remuzzi G. Chronic renal diseases as a public health problem: epidemiology, social, and economic implications. Kidney Int 2005;68:S7–S10
   Web of Science ®Google Scholar
• Schnaper HW, Jandeska S, Runyan CE, et al. TGF-beta signal transduction in chronic kidney disease. Front Biosci 2009;14:2448–2465
   Web of Science ®Google Scholar
• Lan HY. Diverse roles of TGF-β/Smads in renal fibrosis and inflammation. Int J Biol Sci 2011;7:1056–1067
   PubMed Web of Science ®Google Scholar
• Branton MH, Kopp JB. TGF-beta and fibrosis. Microbes Infect 1999;1:1349–1365
   PubMed Web of Science ®Google Scholar
• Chen S, Hong SW, Iglesias-dela Cruz MC, et al. The key role of the transforming growth factor-β system in the pathogenesis of diabetic nephropathy. Ren Fail 2001;23:471–481
   PubMed Web of Science ®Google Scholar
• Hills CE, Squires PE. The role of TGF-β and epithelial-to mesenchymal transition in diabetic nephropathy. Cytokine Growth Factor Rev 2011;22:131–139
   PubMed Web of Science ®Google Scholar
• Mauer SM, Steffes MW, Ellis EN, et al. Structural-functional relationships in diabetic nephropathy. J Clin Invest 1984;74:1143–1155
   PubMed Web of Science ®Google Scholar
• Liu Y. New insights into epithelial-mesenchymal transition in kidney fibrosis. J Am Soc Nephrol 2010;21:212–222
   PubMed Web of Science ®Google Scholar
• Strutz F, Zeisberg M. Renal fibroblasts and myofibroblasts in chronic kidney disease. J Am Soc Nephrol 2006;17:2992–2998
   PubMed Web of Science ®Google Scholar
• Yang J, Liu Y. Dissection of key events in tubular epithelial to myofibroblast transition and its implications in renal interstitial fibrosis. Am J Pathol 2001;159:1465–1475
   PubMed Web of Science ®Google Scholar
• Son H, Moon A. Epithelial-mesenchymal transition and cell invasion. Toxicol Res 2010;26:245–252
   PubMedGoogle Scholar
• Hertig A, Anglicheau D, Verine J, et al. Early epithelial phenotypic changes predict graft fibrosis. J Am Soc Nephrol 2008;19:1584–1591
   PubMed Web of Science ®Google Scholar
• Togawa H, Nakanishi K, Mukaiyama H, et al. Epithelial-to-mesenchymal transition in cyst lining epithelial cells in an orthologous PCK rat model of autosomal-recessive polycystic kidney disease. Am J Physiol Renal Physiol 2011;300:F511–F520
   PubMed Web of Science ®Google Scholar
• Boonla C, Krieglstein K, Bovornpadungkitti S, et al. Fibrosis and evidence for epithelial-mesenchymal transition in the kidneys of patients with staghorn calculi. BJU Int 2011;108:1336–1345
   PubMed Web of Science ®Google Scholar
• Iwano M, Plieth D, Danoff TM, et al. Evidence that fibroblasts derive from epithelium during tissue fibrosis. J Clin Invest 2002;110:341–350
   PubMed Web of Science ®Google Scholar
• Schnaper HW, Hayashida T, Hubchak SC, Poncelet A-C. TGF-beta signal transduction and mesangial cell fibrogenesis. Am J Physiol Renal Physiol 2003;284:F243–F252
   PubMed Web of Science ®Google Scholar
• Rastaldi MP, Ferrario F, Giardino L, et al. Epithelial-mesenchymal transition of tubular epithelial cells in human renal biopsies. Kidney Int 2002;62:137–146
   PubMed Web of Science ®Google Scholar
• Boor P, Ostendorf T, Floege J. Renal fibrosis: novel insights into mechanisms and therapeutic targets. Nat Rev Nephrol 2010;6:643–656
   PubMed Web of Science ®Google Scholar
• Galichon P, Hertig A. Epithelial to mesenchymal transition as a biomarker in renal fibrosis: are we ready for the bedside. Fibrogenesis Tissue Repair 2011;4:11
   PubMedGoogle Scholar
• Kriz W, Kaissling B, Le Hir M. Epithelial-mesenchymal transition (EMT) in kidney fibrosis: fact or fantasy? J Clin Invest 2011;121:468–474
   PubMed Web of Science ®Google Scholar
• Kalluri R, Weinberg RA. The basics of epithelial-mesenchymal transition. J Clin Invest 2009;119:1420–1428
   PubMed Web of Science ®Google Scholar
• Humphreys BD, Lin S-L, Kobayashi A, et al. Fate tracing reveals the pericyte and not epithelial origin of myofibroblasts in kidney fibrosis. Am J Pathol 2010;176:85–97
   PubMed Web of Science ®Google Scholar
• Inoue T, Umezawa A, Takenaka T, et al. The contribution of epithelial-mesenchymal transition to renal fibrosis differs among kidney disease models. Kidney Int 2015;87:233–238
   PubMed Web of Science ®Google Scholar
• Massagué J, Wotton D. Transcriptional control by the TGF-beta/Smad signaling system. EMBO J 2000;19:1745–1754
   PubMed Web of Science ®Google Scholar
• Li Y, Tan X, Dai C, et al. Inhibition of integrin-linked kinase attenuates renal interstitial fibrosis. J Am Soc Nephrol 2009;20:1907–1918
   PubMed Web of Science ®Google Scholar
• Wu Y, Zhou BP. New insights of epithelial‐mesenchymal transition in cancer metastasis. Acta Bioch Bioph Sin 2008;40:643–650
   PubMed Web of Science ®Google Scholar
• Jiang YG, Luo Y, He D, et al. Role of Wnt/β‐catenin signaling pathway in epithelial‐mesenchymal transition of human prostate cancer induced by hypoxia‐inducible factor‐1α. Int J Urol 2007;14:1034–1039
   PubMed Web of Science ®Google Scholar
• Lan HY. Tubular epithelial-myofibroblast transdifferentiation mechanisms in proximal tubule cells. Curr Opin Nephrol Hypertens 2003;12:25–29
   PubMed Web of Science ®Google Scholar
• Bedi S, Vidyasagar A, Djamali A. Epithelial-to-mesenchymal transition and chronic allograft tubulointerstitial fibrosis. Transplant Rev (Orlando) 2008;22:1–5
   PubMedGoogle Scholar
• Fan J-M, Huang X-R, Ng Y-Y, et al. Interleukin-1 induces tubular epithelial-myofibroblast transdifferentiation through a transforming growth factor-β1-dependent mechanism in vitro. Am J Kidney Dis 2001;37:820–831
   PubMed Web of Science ®Google Scholar
• Carvajal G, Rodríguez-Vita J, Rodrigues-Díez R, et al. Angiotensin II activates the Smad pathway during epithelial mesenchymal transdifferentiation. Kidney Int 2008;74:585–595
   PubMed Web of Science ®Google Scholar
• Cheng S, Lovett DH. Gelatinase A (MMP-2) is necessary and sufficient for renal tubular cell epithelial-mesenchymal transformation. Am J Pathol 2003;162:1937–1949
   PubMed Web of Science ®Google Scholar
• Zhang G, Kernan KA, Collins SJ, et al. Plasmin (ogen) promotes renal interstitial fibrosis by promoting epithelial-to-mesenchymal transition: role of plasmin-activated signals. J Am Soc Nephrol 2007;18:846–859
   PubMed Web of Science ®Google Scholar
• Yang J, Shultz RW, Mars WM, et al. Disruption of tissue-type plasminogen activator gene in mice reduces renal interstitial fibrosis in obstructive nephropathy. J Clin Invest 2002;110:1525–1538
   PubMed Web of Science ®Google Scholar
• Djamali A, Reese S, Yracheta J, et al. Epithelial-to-mesenchymal transition and oxidative stress in chronic allograft nephropathy. Am J Transplant 2005;5:500–509
   PubMed Web of Science ®Google Scholar
• Burns WC, Twigg SM, Forbes JM, et al. Connective tissue growth factor plays an important role in advanced glycation end product-induced tubular epithelial-to-mesenchymal transition: implications for diabetic renal disease. J Am Soc Nephrol 2006;17:2484–2494
   PubMed Web of Science ®Google Scholar
• Dennler S, Goumans M-J, Ten Dijke P. Transforming growth factor beta signal transduction. J Leukoc Biol 2002;71:731–740
   PubMed Web of Science ®Google Scholar
• Willis BC, Borok Z. TGF-beta-induced EMT: mechanisms and implications for fibrotic lung disease. Am J Physiol Lung Cell Mol Physiol 2007;293:L525–L534
   PubMed Web of Science ®Google Scholar
• Todorovic V, Jurukovski V, Chen Y, et al. Latent TGF-beta binding proteins. Int J Biochem Cell Biol 2005;37:38–41
   PubMed Web of Science ®Google Scholar
• Kojima S, Nara K, Rifkin DB. Requirement for transglutaminase in the activation of latent transforming growth factor-beta in bovine endothelial cells. J Cell Biol 1993;121:439–448
   PubMed Web of Science ®Google Scholar
• Koli K, Saharinen J, Hyytiäinen M, et al. Latency, activation, and binding proteins of TGF-beta. Microsc Res Techniq 2001;52:354–362
   PubMed Web of Science ®Google Scholar
• Crawford SE, Stellmach V, Murphy-Ullrich JE, et al. Thrombospondin-1 is a major activator of TGF-beta1 in vivo. Cell 1998;93:1159–1170
   PubMed Web of Science ®Google Scholar
• Cantley LC. The phosphoinositide 3-kinase pathway. Science 2002;296:1655–1657
   PubMed Web of Science ®Google Scholar
• Mu D, Cambier S, Fjellbirkeland L, et al. The integrin αvβ8 mediates epithelial homeostasis through MT1-MMP-dependent activation of TGF-β1. J Cell Biol 2002;157:493–507
   PubMed Web of Science ®Google Scholar
• Cheifetz S, Weatherbee JA, Tsang ML-S, et al. The transforming growth factor-beta system, a complex pattern of cross-reactive ligands and receptors. Cell 1987;48:409–415
   PubMed Web of Science ®Google Scholar
• Moustakas A, Heldin C-H. The regulation of TGFbeta signal transduction. Development 2009;136:3699–3714
   PubMed Web of Science ®Google Scholar
• Tsukazaki T, Chiang TA, Davison AF, et al. SARA, a FYVE domain protein that recruits Smad2 to the TGFbeta receptor. Cell 1998;95:779–791
   PubMed Web of Science ®Google Scholar
• Derynck R, Zhang YE. Smad-dependent and Smad-independent pathways in TGF-beta family signalling. Nature 2003;425:577–84
   PubMed Web of Science ®Google Scholar
• Phanish M, Wahab N, Colville-Nash P, et al. The differential role of Smad2 and Smad3 in the regulation of pro-fibrotic TGFbeta1 responses in human proximal-tubule epithelial cells. Biochem J 2006;393:601–607
   PubMed Web of Science ®Google Scholar
• Massagué J, Seoane J, Wotton D. Smad transcription factors. Genes Dev 2005;19:2783–2810
   PubMed Web of Science ®Google Scholar
• Piek E, Moustakas A, Kurisaki A, et al. TGF-(beta) type I receptor/ALK-5 and Smad proteins mediate epithelial to mesenchymal transdifferentiation in NMuMG breast epithelial cells. J Cell Sci 1999;112:4557–4568
   PubMed Web of Science ®Google Scholar
• Hayashi H, Abdollah S, Qiu Y, et al. The MAD-related protein Smad7 associates with the TGFbeta receptor and functions as an antagonist of TGFbeta signaling. Cell 1997;89:1165–1173
   PubMed Web of Science ®Google Scholar
• Nakao A, Afrakhte M, Morn A, et al. Identification of Smad7, a TGFbeta-inducible antagonist of TGF-beta signalling. Nature 1997;389:631–635
   PubMed Web of Science ®Google Scholar
• Akiyoshi S, Inoue H, Hanai J-I, et al. c-Ski acts as a transcriptional co-repressor in transforming growth factor-β signaling through interaction with Smads. J Biol Chem 1999;274:35269–35277
   PubMed Web of Science ®Google Scholar
• Luo K. Ski and SnoN: negative regulators of TGF-beta signaling. Curr Opin Genet Dev 2004;14:65–70
   PubMed Web of Science ®Google Scholar
• Stroschein SL, Wang W, Zhou S, et al. Negative feedback regulation of TGF-beta signaling by the SnoN oncoprotein. . Science 1999;286:771–774
   PubMed Web of Science ®Google Scholar
• Kavsak P, Rasmussen RK, Causing CG, et al. Smad7 binds to Smurf2 to form an E3 ubiquitin ligase that targets the TGF beta receptor for degradation. Mol Cell 2000;6:1365–1375
   PubMed Web of Science ®Google Scholar
• Yang J, Dai C, Liu Y. A novel mechanism by which hepatocyte growth factor blocks tubular epithelial to mesenchymal transition. J Am Soc Nephrol 2005;16:68–78
   PubMed Web of Science ®Google Scholar
• Sato M, Muragaki Y, Saika S, et al. Targeted disruption of TGF-β1/Smad3 signaling protects against renal tubulointerstitial fibrosis induced by unilateral ureteral obstruction. J Clin Invest 2003;112:1486–1494
   PubMed Web of Science ®Google Scholar
• Yang F, Huang XR, Chung AC, et al. Essential role for Smad3 in angiotensin II‐induced tubular epithelial–mesenchymal transition. J Pathol 2010;221:390–401
   PubMed Web of Science ®Google Scholar
• Ju W, Ogawa A, Heyer J, et al. Deletion of Smad2 in mouse liver reveals novel functions in hepatocyte growth and differentiation. Mol Cell Biol 2006;26:654–667
   PubMed Web of Science ®Google Scholar
• Saika S, Ikeda K, Yamanaka O, et al. Adenoviral gene transfer of BMP-7, Id2, or Id3 suppresses injury-induced epithelial-to-mesenchymal transition of lens epithelium in mice. Am J Physiol Cell Physiol 2006;290:C282–C289
   PubMed Web of Science ®Google Scholar
• Zeisberg M, Hanai J-i, Sugimoto H, et al. BMP-7 counteracts TGF-β1-induced epithelial-to-mesenchymal transition and reverses chronic renal injury. Nat Med 2003;9:964–968
   PubMed Web of Science ®Google Scholar
• Zhong X, Chung AC, Chen H-Y, et al. Smad3-mediated upregulation of miR-21 promotes renal fibrosis. J Am Soc Nephrol 2011;22:1668–1681
   PubMed Web of Science ®Google Scholar
• Zhou Q, Chung AC, Huang XR, et al. Identification of novel long noncoding RNAs associated with TGF-β/Smad3-mediated renal inflammation and fibrosis by RNA sequencing. Am J Pathol 2014;184:409–417
   PubMed Web of Science ®Google Scholar
• Moustakas A, Heldin C-H. Non-Smad TGF-beta signals. J Cell Sci 2005;118:3573–3584
   PubMed Web of Science ®Google Scholar
• Atfi A, Djelloul S, Chastre E, et al. Evidence for a role of Rho-like GTPases and stress-activated protein kinase/c-Jun N-terminal kinase (SAPK/JNK) in transforming growth factor β-mediated signaling. J Biol Chem 1997;272:1429–1432
   PubMed Web of Science ®Google Scholar
• Hanafusa H, Ninomiya-Tsuji J, Masuyama N, et al. Involvement of the p38 mitogen-activated protein kinase pathway in transforming growth factor-β-induced gene expression. J Biol Chem 1999;274:27161–27167
   PubMed Web of Science ®Google Scholar
• Edlund S, Landström M, Heldin C-H, Aspenström P. Transforming growth factor-beta-induced mobilization of actin cytoskeleton requires signaling by small GTPases Cdc42 and RhoA. Mol Biol Cell 2002;13:902–914
   PubMed Web of Science ®Google Scholar
• Bhowmick NA, Ghiassi M, Bakin A, et al. Transforming growth factor-β1 mediates epithelial to mesenchymal transdifferentiation through a RhoA-dependent mechanism. Mol Biol Cell 2001;12:27–36
   PubMed Web of Science ®Google Scholar
• Bakin AV, Tomlinson AK, Bhowmick NA, et al. Phosphatidylinositol 3-kinase function is required for transforming growth factor β-mediated epithelial to mesenchymal transition and cell migration. J Biol Chem 2000;275:36803–36810
   PubMed Web of Science ®Google Scholar
• Bielesz B, Sirin Y, Si H, et al. Epithelial Notch signaling regulates interstitial fibrosis development in the kidneys of mice and humans. J Clin Invest 2010;120:4040–4054
   PubMed Web of Science ®Google Scholar
• Zhang P, Cai Y, Soofi A, Dressler GR. Activation of Wnt11 by transforming growth factor-β drives mesenchymal gene expression through non-canonical Wnt protein signaling in renal epithelial cells. J Biol Chem 2012;287:21290–21302
   PubMed Web of Science ®Google Scholar
• Masszi A, Fan L, Rosivall L, et al. Integrity of cell-cell contacts is a critical regulator of TGF-beta 1-induced epithelial-to-myofibroblast transition: role for beta-catenin. Am J Pathol 2004;165:1955–1967
   PubMed Web of Science ®Google Scholar
• Tian W, Zhang Z, Cohen DM. MAPK signaling and the kidney. Am J Physiol Renal Physiol 2000;279:F593–F604
   PubMed Web of Science ®Google Scholar
• Yang C, Patel K, Harding P, et al. Regulation of TGF-β1/MAPK-mediated PAI-1 gene expression by the actin cytoskeleton in human mesangial cells. Exp Cell Res 2007;313:1240–1250
   PubMed Web of Science ®Google Scholar
• Force T, Bonventre JV. Growth factors and mitogen-activated protein kinases. Hypertension 1998;31:152–161
   PubMed Web of Science ®Google Scholar
• Hayashida T, Decaestecker M, Schnaper HW. Cross-talk between ERK MAP kinase and Smad signaling pathways enhances TGF-β-dependent responses in human mesangial cells. FASEB J 2003;17:1576–1578
   PubMed Web of Science ®Google Scholar
• Ma FY, Flanc RS, Tesch GH, et al. A pathogenic role for c-Jun amino-terminal kinase signaling in renal fibrosis and tubular cell apoptosis. J Am Soc Nephrol 2007;18:472–484
   PubMed Web of Science ®Google Scholar
• Hocevar BA, Brown TL, Howe PH. TGF‐β induces fibronectin synthesis through ac‐Jun N‐terminal kinase‐dependent, Smad4‐independent pathway. EMBO J 1999;18:1345–1356
   PubMed Web of Science ®Google Scholar
• Wysk M, Yang DD, Lu H-T, et al. Requirement of mitogen-activated protein kinase kinase 3 (MKK3) for tumor necrosis factor-induced cytokine expression. Proc Natl Acad Sci USA 1999;96:3763–3768
   PubMed Web of Science ®Google Scholar
• Gruden G, Zonca S, Hayward A, et al. Mechanical stretch-induced fibronectin and transforming growth factor-beta1 production in human mesangial cells is p38 mitogen-activated protein kinase-dependent. Diabetes 2000;49:655–661
   PubMed Web of Science ®Google Scholar
• Thornton TM, Pedraza-Alva G, Deng B, et al. Phosphorylation by p38 MAPK as an alternative pathway for GSK3beta inactivation. Science 2008;320:667–670
   PubMed Web of Science ®Google Scholar
• Bhowmick NA, Zent R, Ghiassi M, et al. Integrin beta 1 signaling is necessary for transforming growth factor-beta activation of p38MAPK and epithelial plasticity. J Biol Chem 2001;276:46707–46713
   PubMed Web of Science ®Google Scholar
• Rodríguez-Barbero A, Dorado F, Velasco S, et al. TGF-β1 induces COX-2 expression and PGE2 synthesis through MAPK and PI3K pathways in human mesangial cells. Kidney Int 2006;70:901–909
   PubMed Web of Science ®Google Scholar
• Yi JY, Shin I, Arteaga CL. Type I transforming growth factor β receptor binds to and activates phosphatidylinositol 3-kinase. J Biol Chem 2005;280:10870–10876
   PubMed Web of Science ®Google Scholar
• Docherty NG, O’Sullivan OE, Healy DA, et al. TGF-β1-induced EMT can occur independently of its proapoptotic effects and is aided by EGF receptor activation. Am J Physiol Renal Physiol 2006;290:F1202–F1212
   PubMed Web of Science ®Google Scholar
• Kattla JJ, Carew RM, Heljić M, et al. Protein kinase B/Akt activity is involved in renal TGF-β1-driven epithelial-mesenchymal transition in vitro and in vivo. Am J Physiol Renal Physiol 2008;295:F215–F225
   PubMed Web of Science ®Google Scholar
• Cho HJ, Baek KE, Saika S, et al. Snail is required for transforming growth factor-β-induced epithelial–mesenchymal transition by activating PI3 kinase/Akt signal pathway. Biochem Biophys Res Commun 2007;353:337–343
   PubMed Web of Science ®Google Scholar
• Boutet A, De Frutos CA, Maxwell PH, et al. Snail activation disrupts tissue homeostasis and induces fibrosis in the adult kidney. EMBO J 2006;25:5603–5613
   PubMed Web of Science ®Google Scholar
• Xu J, Lamouille S, Derynck R. TGF-beta-induced epithelial to mesenchymal transition. Cell Res 2009;19:156–172
   PubMed Web of Science ®Google Scholar
• Masszi A, Di Ciano C, Sirokmány G, et al. Central role for Rho in TGF-β1-induced α-smooth muscle actin expression during epithelial-mesenchymal transition. Am J Physiol Renal Physiol 2003;284:F911–F924
   PubMed Web of Science ®Google Scholar
• Ozdamar B, Bose R, Barrios-Rodiles M, et al. Regulation of the polarity protein Par6 by TGFß receptors controls epithelial cell plasticity. Science 2005;307:1603–1609
   PubMed Web of Science ®Google Scholar
• Schweisguth F. Regulation of notch signaling activity. Curr Biol 2004;14:R129–R138
   PubMed Web of Science ®Google Scholar
• Zavadil J, Cermak L, Soto-Nieves N, et al. Integration of TGF-beta/Smad and Jagged1/Notch signalling in epithelial-to-mesenchymal transition. EMBO J 2004;23:1155–1165
   PubMed Web of Science ®Google Scholar
• Niimi H, Pardali K, Vanlandewijck M, et al. Notch signaling is necessary for epithelial growth arrest by TGF-beta. J Cell Biol 2007;176:695–707
   PubMed Web of Science ®Google Scholar
• Böttinger EP, Bitzer M. TGF-beta signaling in renal disease. J Am Soc Nephrol 2002;13:2600–2610
   PubMed Web of Science ®Google Scholar
• Ilagan MXG, Kopan R. SnapShot: notch signaling pathway. Cell 2007;128:1246
   PubMedGoogle Scholar
• Tan RJ, Zhou D, Zhou L, Liu Y. Wnt/β-catenin signaling and kidney fibrosis. Kidney Int Suppl 2014;4:84–90
   PubMed Web of Science ®Google Scholar
• Li Y, Yang J, Dai C, et al. Role for integrin-linked kinase in mediating tubular epithelial to mesenchymal transition and renal interstitial fibrogenesis. J Clin Invest 2003;112:503–516
   PubMed Web of Science ®Google Scholar
• Guo L, Sanders PW, Woods A, Wu C. The distribution and regulation of integrin-linked kinase in normal and diabetic kidneys. Am J Pathol 2001;159:1735–1742
   PubMed Web of Science ®Google Scholar
• Liu Y. Epithelial to mesenchymal transition in renal fibrogenesis: pathologic significance, molecular mechanism, and therapeutic intervention. J Am Soc Nephrol 2004;15:1–12
   PubMed Web of Science ®Google Scholar
• Legate KR, Montañez E, Kudlacek O, Füssler R. ILK, PINCH and parvin: the tIPP of integrin signalling. Nat Rev Mol Cell Biol 2006;7:20–31
   PubMed Web of Science ®Google Scholar
• Zimmet P, Alberti K, Shaw J. Global and societal implications of the diabetes epidemic. Nature 2001;414:782–787
   PubMed Web of Science ®Google Scholar
• Lee HS. Pathogenic role of tGF-β in diabetic nephropathy. J Diabetes Metab 2013;S9:008
   Google Scholar
• Sharma K, McGowan TA. TGF-β in diabetic kidney disease: role of novel signaling pathways. Cytokine Growth Factor Rev 2000;11:115–123
   PubMed Web of Science ®Google Scholar
• Kim Y, Kleppel M, Butkowski R, et al. Differential expression of basement membrane collagen chains in diabetic nephropathy. Am J Pathol 1991;138:413
   PubMed Web of Science ®Google Scholar
• Ayo SH, Radnik RA, Glass W, et al. Increased extracellular matrix synthesis and mRNA in mesangial cells grown in high-glucose medium. Am J Physiol 1991;260:F185–F191
   PubMed Web of Science ®Google Scholar
• Kang BP, Frencher S, Reddy V, et al. High glucose promotes mesangial cell apoptosis by oxidant-dependent mechanism. Am J Physiol Renal Physiol 2003;284:F455–F466
   PubMed Web of Science ®Google Scholar
• Vidotti D, Casarini D, Cristovam P, et al. High glucose concentration stimulates intracellular renin activity and angiotensin II generation in rat mesangial cells. Am J Physiol Renal Physiol 2004;286:F1039–F1045
   PubMed Web of Science ®Google Scholar
• Lee HS. Pathogenic role of TGF-β in the progression of podocyte diseases. Histol Histopathol 2011;26:107–116
   PubMed Web of Science ®Google Scholar
• Rerolle J-P, Hertig A, Nguyen G, et al. Plasminogen activator inhibitor type 1 is a potential target in renal fibrogenesis. Kidney Int 2000;58:1841–1850
   PubMed Web of Science ®Google Scholar
• Huang Y, Wongamorntham S, Kasting J, et al. Renin increases mesangial cell transforming growth factor-β1 and matrix proteins through receptor-mediated, angiotensin II-independent mechanisms. Kidney Int 2006;69:105–113
   PubMed Web of Science ®Google Scholar
• Wautier J, Guillausseau P. Advanced glycation end products, their receptors and diabetic angiopathy. Diabetes Metab 2001;27:535–542
   PubMed Web of Science ®Google Scholar
• Forbes JM, Cooper ME, Oldfield MD, Thomas MC. Role of advanced glycation end products in diabetic nephropathy. J Am Soc Nephrol 2003;14:S254–S258
   PubMed Web of Science ®Google Scholar
• Yang C-W, Vlassara H, Peten EP, et al. Advanced glycation end products up-regulate gene expression found in diabetic glomerular disease. Proc Natl Acad Sci USA 1994;91:9436–9440
   PubMed Web of Science ®Google Scholar
• Wautier M-P, Chappey O, Corda S, et al. Activation of NADPH oxidase by AGE links oxidant stress to altered gene expression via RAGE. Am J Physiol Endoc M 2001;280:E685–E694
   PubMed Web of Science ®Google Scholar
• Kitsiou PV, Tzinia AK, Stetler-Stevenson WG, et al. Glucose-induced changes in integrins and matrix-related functions in cultured human glomerular epithelial cells. Am J Physiol Renal Physiol 2003;284:F671–F679
   PubMed Web of Science ®Google Scholar
• Munger JS, Huang X, Kawakatsu H, et al. The integrin αvβ6 binds and activates latent TGFβ1: a mechanism for regulating pulmonary inflammation and fibrosis. Cell 1999;96:319–328
   PubMed Web of Science ®Google Scholar
• Koli K, Myllärniemi M, Keski-Oja J, Kinnula VL. Transforming growth factor-beta activation in the lung: focus on fibrosis and reactive oxygen species. Antioxid Redox Signal 2008;10:333–342
   PubMed Web of Science ®Google Scholar
• Pezzolesi MG, Satake E, McDonnell KP, et al. Circulating TGF-β1-regulated miRNAs and the risk of rapid progression to ESRD in type 1 diabetes. Diabetes 2015;64:3285–3293
   PubMed Web of Science ®Google Scholar
• Krupa A, Jenkins R, Luo DD, et al. Loss of MicroRNA-192 promotes fibrogenesis in diabetic nephropathy. J Am Soc Nephrol 2010;21:438–447
   PubMed Web of Science ®Google Scholar
• Putta S, Lanting L, Sun G, et al. Inhibiting microRNA-192 ameliorates renal fibrosis in diabetic nephropathy. J Am Soc Nephrol 2012;23:458–469
   PubMed Web of Science ®Google Scholar
• Wang Q, Wang Y, Minto AW, et al. MicroRNA-377 is up-regulated and can lead to increased fibronectin production in diabetic nephropathy. FASEB J 2008;22:4126–4135
   PubMed Web of Science ®Google Scholar
• Du B, Ma L-M, Huang M-B, et al. High glucose down-regulates miR-29a to increase collagen IV production in HK-2 cells. FEBS Lett 2010;584:811–816
   PubMed Web of Science ®Google Scholar
• Bonegio RG, Fuhro R, Wang Z, et al. Rapamycin ameliorates proteinuria-associated tubulointerstitial inflammation and fibrosis in experimental membranous nephropathy. J Am Soc Nephrol 2005;16:2063–2072
   PubMed Web of Science ®Google Scholar
• Schieppati A, Ruggenenti P, Perna A, Remuzzi G, editors. Nonimmunosuppressive therapy of membranous nephropathy. Semin Nephrol 2003;23:333–339
   PubMed Web of Science ®Google Scholar
• Couser WG, Nangaku M. Cellular and molecular biology of membranous nephropathy. J Nephrol 2005;19:699–705
   Web of Science ®Google Scholar
• Ronco P, Debiec H. Molecular pathomechanisms of membranous nephropathy: from Heymann nephritis to alloimmunization. J Am Soc Nephrol 2005;16:1205–1213
   PubMed Web of Science ®Google Scholar
• Kim TS, Kim JY, Hong HK, Lee HS. mRNA expression of glomerular basement membrane proteins and TGF‐β 1 in human membranous nephropathy. J Pathol 1999;189:425–430
   PubMed Web of Science ®Google Scholar
• Ren G, Huynh C, Bijian K, Cybulsky AV. Role of apoptosis signal-regulating kinase 1 in complement-mediated glomerular epithelial cell injury. Mol Immunol 2008;45:2236–2246
   PubMed Web of Science ®Google Scholar
• Mudge SJ, Paizis K, Auwardt RB, et al. Activation of nuclear factor-&kgr; B by podocytes in the autologous phase of passive Heymann nephritis. Kidney Int 2001;59:923–931
   PubMed Web of Science ®Google Scholar
• Zahner G, Harendza S, Muller E, et al. Prostaglandin E2 stimulates expression of matrix metalloproteinase 2 in cultured rat mesangial cells. Kidney Int 1997;51:1116–1123
   PubMed Web of Science ®Google Scholar
• Jobling MF, Mott JD, Finnegan MT, et al. Isoform-specific activation of latent transforming growth factor β (LTGF-β) by reactive oxygen species. Radiat Res 2006;166:839–848
   PubMed Web of Science ®Google Scholar
• Yu Q, Stamenkovic I. Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-beta and promotes tumor invasion and angiogenesis. Genes Dev 2000;14:163–176
   PubMed Web of Science ®Google Scholar
• Gao L, Qiu W, Wang Y, et al. Sublytic complement C5b‐9 complexes induce thrombospondin‐1 production in rat glomerular mesangial cells via PI3‐k/Akt: association with activation of latent transforming growth factor‐β1. Clin Exp Imm 2006;144:326–334
   PubMed Web of Science ®Google Scholar
• Kim JH, Kim BK, Moon KC, et al. Activation of the TGF-beta/Smad signaling pathway in focal segmental glomerulosclerosis. Kidney Int 2003;64:1715–1721
   PubMed Web of Science ®Google Scholar
• Wahab N, Schaefer L, Weston B, et al. Glomerular expression of thrombospondin-1, transforming growth factor beta and connective tissue growth factor at different stages of diabetic nephropathy and their interdependent roles in mesangial response to diabetic stimuli. Diabetologia 2005;48:2650–2660
   PubMed Web of Science ®Google Scholar
• Hugo C, Shankland SJ, Pichler RH, et al. Thrombospondin 1 precedes and predicts the development of tubulointerstitial fibrosis in glomerular disease in the rat. Kidney Int 1998;53:302–311
   PubMed Web of Science ®Google Scholar